$FCHS
First Choice Healthcare Solutions Inc Stock $fchs

$fchs Overview Financials Valuation SEC Filings Company Website

2013 Form 10-K Financial Statement

#000114420414019627 Filed on March 31, 2014

Income Statement

Concept	2013	2012 Q4	2012
Revenue	$1.048M	$1.210M	$1.160M
YoY Change	-9.62%	266.67%	-10.77%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin	$1.705M	$600.0K	$1.314M
YoY Change	29.74%	-91.18%	-82.41%
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$518.6K	$120.0K	$309.9K
YoY Change	67.35%	200.0%	93.69%
% of Gross Profit
Operating Expenses	$7.121M	$1.290M	$4.083M
YoY Change	74.4%	-81.14%	-46.49%
Operating Profit	-$978.2K		-$277.7K
YoY Change	252.18%
Interest Expense	$3.704M	-$210.0K	$563.4K
YoY Change	557.46%	90.91%	-260.97%
% of Operating Profit
Other Income/Expense, Net	-$3.726M	$0.00	-$618.7K
YoY Change	502.23%		-1646.82%
Pretax Income	-$4.704M	-$280.0K	-$896.5K
YoY Change	424.76%	-95.77%	-86.36%
Income Tax	$0.00	$0.00	-$23.10K
% Of Pretax Income
Net Earnings	-$4.704M	-$280.0K	-$873.4K
YoY Change	438.64%	-95.76%	-86.69%
Net Earnings / Revenue	-448.68%	-23.14%	-75.29%
Basic Earnings Per Share	-$0.35		-$0.07
Diluted Earnings Per Share	-$0.35	-$0.02	-$0.07
COMMON SHARES
Basic Shares Outstanding	13.53M shares		12.64M shares
Diluted Shares Outstanding	13.53M shares		12.64M shares

Balance Sheet

Concept	2013	2012 Q4	2012
SHORT-TERM ASSETS
Cash & Short-Term Investments	$739.2K	$70.00K	$67.05K
YoY Change	1002.4%	-86.79%	-87.35%
Cash & Equivalents		$67.05K
Short-Term Investments
Other Short-Term Assets	$454.2K	$350.0K	$348.5K
YoY Change	30.33%	-70.34%	-70.47%
Inventory
Prepaid Expenses
Receivables	$1.272M	$527.9K	$527.9K
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$2.465M	$943.4K	$943.4K
YoY Change	161.35%	-53.07%	-53.07%
LONG-TERM ASSETS
Property, Plant & Equipment	$8.662M	$8.757M	$8.757M
YoY Change	-1.08%	92.88%	92.88%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$134.3K	$431.2K	$155.6K
YoY Change	-13.74%	87.5%	-32.33%
Total Long-Term Assets	$9.348M	$9.188M	$9.188M
YoY Change	1.74%	93.02%	93.02%
TOTAL ASSETS
Total Short-Term Assets	$2.465M	$943.4K	$943.4K
Total Long-Term Assets	$9.348M	$9.188M	$9.188M
Total Assets	$11.81M	$10.13M	$10.13M
YoY Change	16.6%	49.65%	49.65%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$459.0K	$580.0K	$576.2K
YoY Change	-20.34%	222.22%	220.12%
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due	$1.544M	$1.030M	$1.034M
YoY Change	49.29%	1044.44%	1049.02%
Total Short-Term Liabilities	$2.244M	$1.650M	$1.650M
YoY Change	36.02%	415.55%	415.55%
LONG-TERM LIABILITIES
Long-Term Debt	$11.28M	$9.783M	$9.564M
YoY Change	17.98%	31.49%	27.86%
Other Long-Term Liabilities	$72.90K	$220.0K	$219.4K
YoY Change	-66.77%	340.0%
Total Long-Term Liabilities	$11.36M	$9.783M	$9.783M
YoY Change	16.08%	30.61%	30.79%
TOTAL LIABILITIES
Total Short-Term Liabilities	$2.244M	$1.650M	$1.650M
Total Long-Term Liabilities	$11.36M	$9.783M	$9.783M
Total Liabilities	$13.60M	$11.43M	$11.43M
YoY Change	18.95%	46.57%	46.57%
SHAREHOLDERS EQUITY
Retained Earnings		-$8.659M
YoY Change
Common Stock		$12.71K
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	-$1.787M	-$1.302M	-$1.302M
YoY Change
Total Liabilities & Shareholders Equity	$11.81M	$10.13M	$10.13M
YoY Change	16.6%	49.65%	49.65%

Cashflow Statement

Concept	2013	2012 Q4	2012
OPERATING ACTIVITIES
Net Income	-$4.704M	-$280.0K	-$873.4K
YoY Change	438.64%	-95.76%	-86.69%
Depreciation, Depletion And Amortization	$518.6K	$120.0K	$309.9K
YoY Change	67.35%	200.0%	93.69%
Cash From Operating Activities	-$1.264M	-$70.00K	-$788.9K
YoY Change	60.24%	-12.5%	-1226.93%
INVESTING ACTIVITIES
Capital Expenditures	$397.7K	$300.0K	$2.917M
YoY Change	-86.37%	-65.91%	191.68%
Acquisitions
YoY Change
Other Investing Activities	$25.50K	$10.00K	$64.56K
YoY Change	-60.5%	-200.0%	-745.6%
Cash From Investing Activities	-$372.2K	-$280.0K	-$2.852M
YoY Change	-86.95%	-68.54%	182.4%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net	$0.00		$100.0K
YoY Change	-100.0%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	2.308M	220.0K	3.180M
YoY Change	-27.41%	-1200.0%	116.32%
NET CHANGE
Cash From Operating Activities	-1.264M	-70.00K	-788.9K
Cash From Investing Activities	-372.2K	-280.0K	-2.852M
Cash From Financing Activities	2.308M	220.0K	3.180M
Net Change In Cash	672.1K	-130.0K	-461.3K
YoY Change	-245.71%	-86.87%	-187.03%
FREE CASH FLOW
Cash From Operating Activities	-$1.264M	-$70.00K	-$788.9K
Capital Expenditures	$397.7K	$300.0K	$2.917M
Free Cash Flow	-$1.662M	-$370.0K	-$3.706M
YoY Change	-55.16%	-61.46%	298.46%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2013Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	739158	USD
CY2013Q4	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	256246	USD
CY2012Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	527867	USD
CY2013Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	1272155	USD
CY2012Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	69970	USD
CY2013Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	140580	USD
CY2012Q4	us-gaap	Deferred Finance Costs Current Net DeferredFinanceCostsCurrentNet	57348	USD
CY2013Q4	us-gaap	Deferred Finance Costs Current Net DeferredFinanceCostsCurrentNet	57348	USD
CY2012Q4	us-gaap	Assets Current AssetsCurrent	943378	USD
CY2013Q4	us-gaap	Assets Current AssetsCurrent	2465487	USD
CY2012Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	8756631	USD
CY2013Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	8662057	USD
CY2012Q4	us-gaap	Deferred Finance Costs Noncurrent Net DeferredFinanceCostsNoncurrentNet	152911	USD
CY2013Q4	us-gaap	Deferred Finance Costs Noncurrent Net DeferredFinanceCostsNoncurrentNet	131540	USD
CY2012Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	275609	USD
CY2013Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	265000	USD
CY2012Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	67045	USD
CY2012Q4	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	221148	USD
CY2012Q4	us-gaap	Deposits Assets Noncurrent DepositsAssetsNoncurrent	2719	USD
CY2013Q4	us-gaap	Deposits Assets Noncurrent DepositsAssetsNoncurrent	2713	USD
CY2012Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	431239	USD
CY2013Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	685753	USD
CY2012Q4	us-gaap	Assets Assets	10131248	USD
CY2013Q4	us-gaap	Assets Assets	11813297	USD
CY2012Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	576209	USD
CY2013Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	459000	USD
CY2012Q4	us-gaap	Notes Payable Current NotesPayableCurrent	690586	USD
CY2013Q4	us-gaap	Notes Payable Current NotesPayableCurrent	743787	USD
CY2012Q4	us-gaap	Convertible Notes Payable Current ConvertibleNotesPayableCurrent	43537	USD
CY2013Q4	us-gaap	Convertible Notes Payable Current ConvertibleNotesPayableCurrent	0	USD
CY2012Q4	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	39438	USD
CY2013Q4	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	74934	USD
CY2012Q4	us-gaap	Liabilities Current LiabilitiesCurrent	1649770	USD
CY2013Q4	us-gaap	Liabilities Current LiabilitiesCurrent	2244061	USD
CY2012Q4	us-gaap	Customer Deposits Noncurrent CustomerDepositsNoncurrent	47399	USD
CY2013Q4	us-gaap	Customer Deposits Noncurrent CustomerDepositsNoncurrent	72901	USD
CY2012Q4	us-gaap	Due To Related Parties Noncurrent DueToRelatedPartiesNoncurrent	153330	USD
CY2013Q4	us-gaap	Due To Related Parties Noncurrent DueToRelatedPartiesNoncurrent	0	USD
CY2012Q4	us-gaap	Long Term Notes Payable LongTermNotesPayable	9410296	USD
CY2013Q4	us-gaap	Long Term Notes Payable LongTermNotesPayable	8935473	USD
CY2012Q4	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	171987	USD
CY2013Q4	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	0	USD
CY2012Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	9783012	USD
CY2013Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	11355777	USD
CY2012Q4	us-gaap	Liabilities Liabilities	11432782	USD
CY2013Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-13363537	USD
CY2012Q4	us-gaap	Stockholders Equity StockholdersEquity	-1301534	USD
CY2013Q4	us-gaap	Stockholders Equity StockholdersEquity	-1786541	USD
CY2013Q4	us-gaap	Liabilities Liabilities	13599838	USD
CY2012Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2013Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2012Q4	us-gaap	Common Stock Value CommonStockValue	12707	USD
CY2013Q4	us-gaap	Common Stock Value CommonStockValue	16747	USD
CY2012Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	7244993	USD
CY2013Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	11560249	USD
CY2012Q4	us-gaap	Common Stock Shares Subscriptions CommonStockSharesSubscriptions	100000	USD
CY2013Q4	us-gaap	Common Stock Shares Subscriptions CommonStockSharesSubscriptions	0	USD
CY2012Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-8659234	USD
CY2012Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	10131248	USD
CY2013Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	11813297	USD
CY2012Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	1465939	USD
CY2013Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	1959127	USD
CY2012Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	24391	USD
CY2013Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	35000	USD
CY2012Q4	us-gaap	Debt Instrument Unamortized Discount DebtInstrumentUnamortizedDiscount	160543	USD
CY2012Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2013Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2012Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	1000000	shares
CY2013Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	1000000	shares
CY2012Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2013Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2012Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2013Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2012Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2013Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2012Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000	shares
CY2013Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000	shares
CY2012Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	12706795	shares
CY2013Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	16747248	shares
CY2012Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	12706795	shares
CY2013Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	16747248	shares
CY2012	us-gaap	Health Care Organization Patient Service Revenue HealthCareOrganizationPatientServiceRevenue	2645310	USD
CY2013	us-gaap	Health Care Organization Patient Service Revenue HealthCareOrganizationPatientServiceRevenue	5459373	USD
CY2012	us-gaap	Revenues Revenues	1160037	USD
CY2013	us-gaap	Revenues Revenues	1048469	USD
CY2012	us-gaap	Sales Revenue Net SalesRevenueNet	3805347	USD
CY2013	us-gaap	Sales Revenue Net SalesRevenueNet	6507842	USD
CY2012	us-gaap	Labor And Related Expense LaborAndRelatedExpense	1593245	USD
CY2013	us-gaap	Labor And Related Expense LaborAndRelatedExpense	3096285	USD
CY2012	us-gaap	Other General Expense OtherGeneralExpense	865641	USD
CY2013	us-gaap	Other General Expense OtherGeneralExpense	1715942	USD
CY2012	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	1314302	USD
CY2013	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	1705154	USD
CY2012	us-gaap	Depreciation And Amortization DepreciationAndAmortization	309899	USD
CY2013	us-gaap	Depreciation And Amortization DepreciationAndAmortization	518611	USD
CY2012	us-gaap	Operating Expenses OperatingExpenses	4083087	USD
CY2013	us-gaap	Operating Expenses OperatingExpenses	7485992	USD
CY2012	us-gaap	Operating Income Loss OperatingIncomeLoss	-277740	USD
CY2013	us-gaap	Operating Income Loss OperatingIncomeLoss	-978150	USD
CY2012	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	3000	USD
CY2013	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	3063	USD
CY2012	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	57348	USD
CY2013	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	57348	USD
CY2012	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	-563391	USD
CY2013	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	-3704086	USD
CY2012	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-618726	USD
CY2013	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-3726153	USD
CY2012	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-896466	USD
CY2013	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-4704303	USD
CY2012	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-23103	USD
CY2013	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	USD
CY2012	us-gaap	Net Income Loss NetIncomeLoss	-873363	USD
CY2013	us-gaap	Net Income Loss NetIncomeLoss	-4704303	USD
CY2011Q4	us-gaap	Stockholders Equity StockholdersEquity	-1025896	USD
CY2013	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	383101	USD
CY2012	us-gaap	Stock Issued During Period Value Acquisitions StockIssuedDuringPeriodValueAcquisitions	497725	USD
CY2013	us-gaap	Stock Issued During Period Value Acquisitions StockIssuedDuringPeriodValueAcquisitions	450000	USD
CY2012	fchs	Stock Issued During Period Value Common Stock Shares Subscriptions StockIssuedDuringPeriodValueCommonStockSharesSubscriptions	100000	USD
CY2012	us-gaap	Depreciation Nonproduction DepreciationNonproduction	309899	USD
CY2013	us-gaap	Depreciation Nonproduction DepreciationNonproduction	518611	USD
CY2012	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	10457	USD
CY2013	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	2706869	USD
CY2012	us-gaap	Share Based Compensation ShareBasedCompensation	0	USD
CY2013	us-gaap	Share Based Compensation ShareBasedCompensation	549441	USD
CY2012	us-gaap	Derivative Loss On Derivative DerivativeLossOnDerivative	987	USD
CY2013	us-gaap	Derivative Loss On Derivative DerivativeLossOnDerivative	-32218	USD
CY2012	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	329375	USD
CY2013	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	1105572	USD
CY2012	fchs	Increase Decrease In Other Accounts Receivable IncreaseDecreaseInOtherAccountsReceivable	205000	USD
CY2013	fchs	Increase Decrease In Other Accounts Receivable IncreaseDecreaseInOtherAccountsReceivable	0	USD
CY2012	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	40265	USD
CY2013	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	70604	USD
CY2012	us-gaap	Increase Decrease In Restricted Cash And Investments IncreaseDecreaseInRestrictedCashAndInvestments	131209	USD
CY2013	us-gaap	Increase Decrease In Restricted Cash And Investments IncreaseDecreaseInRestrictedCashAndInvestments	35098	USD
CY2012	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	419417	USD
CY2013	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-91312	USD
CY2012	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	15354	USD
CY2013	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	35496	USD
CY2012	us-gaap	Increase Decrease In Deferred Income Taxes IncreaseDecreaseInDeferredIncomeTaxes	23103	USD
CY2013	us-gaap	Increase Decrease In Deferred Income Taxes IncreaseDecreaseInDeferredIncomeTaxes	0	USD
CY2012	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	-788853	USD
CY2013	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	-1264058	USD
CY2012	us-gaap	Payments To Acquire Businesses And Interest In Affiliates PaymentsToAcquireBusinessesAndInterestInAffiliates	143366	USD
CY2013	us-gaap	Payments To Acquire Businesses And Interest In Affiliates PaymentsToAcquireBusinessesAndInterestInAffiliates	0	USD
CY2012	us-gaap	Equipment Expense EquipmentExpense	-2773450	USD
CY2013	us-gaap	Equipment Expense EquipmentExpense	-397688	USD
CY2012	us-gaap	Net Cash Provided By Used In Investing Activities Continuing Operations NetCashProvidedByUsedInInvestingActivitiesContinuingOperations	-2852259	USD
CY2013	us-gaap	Net Cash Provided By Used In Investing Activities Continuing Operations NetCashProvidedByUsedInInvestingActivitiesContinuingOperations	-372186	USD
CY2012	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	2871058	USD
CY2013	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	152659	USD
CY2012	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt	203500	USD
CY2013	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt	2128117	USD
CY2012	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	100000	USD
CY2013	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	0	USD
CY2012	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	184704	USD
CY2013	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	1334781	USD
CY2012	us-gaap	Net Cash Provided By Used In Financing Activities Continuing Operations NetCashProvidedByUsedInFinancingActivitiesContinuingOperations	3179854	USD
CY2013	us-gaap	Net Cash Provided By Used In Financing Activities Continuing Operations NetCashProvidedByUsedInFinancingActivitiesContinuingOperations	2308357	USD
CY2012	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	-461258	USD
CY2013	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	3414070	shares
CY2013	us-gaap	Depreciation Depreciation	483797	USD
CY2013	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	672113	USD
CY2011Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	528303	USD
CY2012Q4	us-gaap	Accumulated Amortization Deferred Finance Costs AccumulatedAmortizationDeferredFinanceCosts	76464	USD
CY2012	us-gaap	Interest Paid InterestPaid	467670	USD
CY2013	us-gaap	Interest Paid InterestPaid	731877	USD
CY2012	us-gaap	Income Taxes Paid IncomeTaxesPaid	0	USD
CY2013	us-gaap	Income Taxes Paid IncomeTaxesPaid	0	USD
CY2012	fchs	Common Stock Issued For Acquisition CommonStockIssuedForAcquisition	497725	USD
CY2013	fchs	Common Stock Issued For Acquisition CommonStockIssuedForAcquisition	0	USD
CY2013	us-gaap	Use Of Estimates UseOfEstimates	<div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt" align="justify"><u><font style="FONT-SIZE: 10pt">Use of Estimates</font></u></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-SIZE: 10pt"> </font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-SIZE: 10pt">The preparation of the financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect certain reported amounts and disclosures. Accordingly, actual results could differ from those estimates.</font></div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table>
CY2013	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt" align="justify"><u><font style="FONT-SIZE: 10pt">Concentrations of Credit Risk</font></u></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-SIZE: 10pt"> </font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-SIZE: 10pt">The Company’s financial instruments that are exposed to a concentration of credit risk are cash and accounts receivable. Generally, the Company’s cash and cash equivalents in interest-bearing accounts may exceed FDIC insurance limits. The financial stability of these institutions is periodically reviewed by senior management.</font></div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table>
CY2013Q4	us-gaap	Accumulated Amortization Deferred Finance Costs AccumulatedAmortizationDeferredFinanceCosts	133812	USD
CY2013	us-gaap	Business Acquisition Name Of Acquired Entity BusinessAcquisitionNameOfAcquiredEntity	First Choice Medical Group of Brevard, LLC
CY2013	us-gaap	Business Acquisition Description Of Acquired Entity BusinessAcquisitionDescriptionOfAcquiredEntity	First Choice - Brevard is a multi-specialty medical group including orthopedics (both operative and non-operative), sports medicine, pain management and neurology. The practice is located in Marina Towers, a Class A office building owned by the Company.
CY2013	us-gaap	Business Acquisition Preexisting Relationship Description BusinessAcquisitionPreexistingRelationshipDescription	The Company has been managing the practice of First Choice Brevard since November 1, 2011, pursuant to a Management Services Agreement (the Management Agreement).
CY2013	fchs	Investment Maturity Term InvestmentMaturityTerm	90 days or less
CY2013	us-gaap	Property Plant And Equipment Depreciation Methods PropertyPlantAndEquipmentDepreciationMethods	straight-line method
CY2013	us-gaap	Business Acquisition Effective Date Of Acquisition1 BusinessAcquisitionEffectiveDateOfAcquisition1	2012-04-02
CY2012Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	0	USD
CY2013Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	361284	USD
CY2012	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	2029686	shares
CY2012Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	10222570	USD
CY2013Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	10621184	USD
CY2012	us-gaap	Depreciation Depreciation	309899	USD
CY2013Q3	us-gaap	Debt Instrument Interest Rate Stated Percentage DebtInstrumentInterestRateStatedPercentage	0.08	pure
CY2013Q4	us-gaap	Debt Instrument Interest Rate Stated Percentage DebtInstrumentInterestRateStatedPercentage	0.08	pure
CY2012Q4	us-gaap	Notes Payable NotesPayable	10100882	USD
CY2013Q4	us-gaap	Notes Payable NotesPayable	9679260	USD
CY2011Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	12462750	shares
CY2011Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	12462750	shares
CY2012	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1314302	USD
CY2013	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1705154	USD
CY2012	us-gaap	Interest Expense InterestExpense	563391	USD
CY2013	us-gaap	Interest Expense InterestExpense	3704086	USD
CY2012	us-gaap	Payments To Acquire Machinery And Equipment PaymentsToAcquireMachineryAndEquipment	2773450	USD
CY2013	us-gaap	Payments To Acquire Machinery And Equipment PaymentsToAcquireMachineryAndEquipment	397688	USD
CY2013Q4	us-gaap	Contractual Obligation Due In Next Twelve Months ContractualObligationDueInNextTwelveMonths	8411	USD
CY2013Q4	us-gaap	Contractual Obligation Due In Second Year ContractualObligationDueInSecondYear	16835	USD
CY2013Q4	us-gaap	Contractual Obligation ContractualObligation	25246	USD
CY2012	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.07
CY2013	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.35
CY2012	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	12644784	shares
CY2013	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	13529294	shares
CY2012	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.07
CY2013	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.35
CY2012	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	12644784	shares
CY2013	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	13529294	shares
CY2012Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	0	USD
CY2013Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	490000	USD
CY2012Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	0	USD
CY2013Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	490000	USD
CY2012Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	0	USD
CY2013Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	0	USD
CY2012	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	0	USD
CY2013	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	0	USD
CY2012	us-gaap	Income Tax Reconciliation Prior Year Income Taxes IncomeTaxReconciliationPriorYearIncomeTaxes	-23103	USD
CY2013	us-gaap	Income Tax Reconciliation Prior Year Income Taxes IncomeTaxReconciliationPriorYearIncomeTaxes	0	USD
CY2012	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.350	pure
CY2013	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.350	pure
CY2012	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0	pure
CY2013	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0	pure
CY2012	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.350	pure
CY2013	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.350	pure
CY2012	fchs	Shares To Be Returned From Post Acquisition Adjustments Number Of Shares SharesToBeReturnedFromPostAcquisitionAdjustmentsNumberOfShares	70529	shares
CY2013Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Next Twelve Months LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths	743787	USD
CY2013Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Two LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo	715085	USD
CY2013Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Three LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree	7632286	USD
CY2013Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Four LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour	523608	USD
CY2013Q4	us-gaap	Long Term Debt LongTermDebt	9679260	USD
CY2012Q4	us-gaap	Finite Lived Patents Gross FiniteLivedPatentsGross	0	USD
CY2013Q4	us-gaap	Finite Lived Patents Gross FiniteLivedPatentsGross	286500	USD
CY2012Q4	us-gaap	Lines Of Credit Current LinesOfCreditCurrent	0	USD
CY2013Q4	us-gaap	Lines Of Credit Current LinesOfCreditCurrent	800000	USD
CY2012	us-gaap	Increase Decrease In Other Deposits IncreaseDecreaseInOtherDeposits	15796	USD
CY2013	us-gaap	Increase Decrease In Other Deposits IncreaseDecreaseInOtherDeposits	25502	USD
CY2013Q4	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Other Noncurrent Assets BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets	300000	USD
CY2012Q4	us-gaap	Notes Payable Related Parties Classified Current NotesPayableRelatedPartiesClassifiedCurrent	300000	USD
CY2013Q4	us-gaap	Notes Payable Related Parties Classified Current NotesPayableRelatedPartiesClassifiedCurrent	0	USD
CY2012	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	-987	USD
CY2013	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	32218	USD
CY2012	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.07
CY2013	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.35
CY2012	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	12644784	shares
CY2013Q4	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Assets BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets	2405651	USD
CY2012	us-gaap	Proceeds From Repayments Of Related Party Debt ProceedsFromRepaymentsOfRelatedPartyDebt	190000	USD
CY2013	us-gaap	Proceeds From Repayments Of Related Party Debt ProceedsFromRepaymentsOfRelatedPartyDebt	-10846	USD
CY2013Q4	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Current Liabilities Accounts Payable BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable	44802	USD
CY2013Q4	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Property Plant And Equipment BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment	1731590	USD
CY2013Q4	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Net BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet	2360849	USD
CY2013	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	13529294	shares
CY2013	fchs	Common Stock Issued For Subscription CommonStockIssuedForSubscription	0	USD
CY2012	us-gaap	Cash Acquired From Acquisition CashAcquiredFromAcquisition	48761	USD
CY2013	us-gaap	Cash Acquired From Acquisition CashAcquiredFromAcquisition	0	USD
CY2012	us-gaap	Proceeds From Lines Of Credit ProceedsFromLinesOfCredit	0	USD
CY2013	us-gaap	Proceeds From Lines Of Credit ProceedsFromLinesOfCredit	1373208	USD
CY2013Q4	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Cash And Equivalents BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents	48761	USD
CY2013Q4	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Current Assets Receivables BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables	325300	USD
CY2013Q4	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Current Assets BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets	374061	USD
CY2012	us-gaap	Fair Value Of Assets Acquired FairValueOfAssetsAcquired	0	USD
CY2013	us-gaap	Fair Value Of Assets Acquired FairValueOfAssetsAcquired	286500	USD
CY2012	fchs	Common Stock Issued To Acquire10 Interest In Medtech Diagnostics Llc CommonStockIssuedToAcquire10InterestInMedtechDiagnosticsLlc	0	USD
CY2013	fchs	Common Stock Issued To Acquire10 Interest In Medtech Diagnostics Llc CommonStockIssuedToAcquire10InterestInMedtechDiagnosticsLlc	450000	USD
CY2012	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	15000	USD
CY2013	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	20000	USD
CY2013	us-gaap	Costmethod Investments Other Than Temporary Impairment CostmethodInvestmentsOtherThanTemporaryImpairment	450000	USD
CY2013Q4	us-gaap	Cost Method Investments CostMethodInvestments	0	USD
CY2013	fchs	Cost Method Investments Other Than Temporary Impairment Per Share CostMethodInvestmentsOtherThanTemporaryImpairmentPerShare	0.03
CY2013	us-gaap	Stock Issued During Period Value Purchase Of Assets StockIssuedDuringPeriodValuePurchaseOfAssets	286500	USD
CY2012Q4	us-gaap	Deferred Compensation Share Based Arrangements Liability Current DeferredCompensationShareBasedArrangementsLiabilityCurrent	0	USD
CY2013Q4	us-gaap	Deferred Compensation Share Based Arrangements Liability Current DeferredCompensationShareBasedArrangementsLiabilityCurrent	166340	USD
CY2012Q4	us-gaap	Convertible Long Term Notes Payable ConvertibleLongTermNotesPayable	0	USD
CY2013Q4	us-gaap	Convertible Long Term Notes Payable ConvertibleLongTermNotesPayable	2347403	USD
CY2012	us-gaap	Costmethod Investments Other Than Temporary Impairment CostmethodInvestmentsOtherThanTemporaryImpairment	0	USD
CY2013	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities Net Of Adjustments StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustments	624000	USD
CY2013	dei	Document Type DocumentType	10-K
CY2013	dei	Amendment Flag AmendmentFlag	false
CY2013	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2013	dei	Document Period End Date DocumentPeriodEndDate	2013-12-31
CY2013	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2013
CY2013Q4	us-gaap	Convertible Notes Payable ConvertibleNotesPayable	2347403	USD
CY2013Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Five LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive	64494	USD
CY2012	us-gaap	Adjustments To Additional Paid In Capital Convertible Debt With Conversion Feature AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature	0	USD
CY2012	fchs	Adjustments To Additional Paid In Capital Reclassification Of Derivative Liability To Equity AdjustmentsToAdditionalPaidInCapitalReclassificationOfDerivativeLiabilityToEquity	0	USD
CY2013	fchs	Stock Issued For Loan Modification StockIssuedForLoanModification	-96000	USD
CY2012	us-gaap	Stock Issued1 StockIssued1	0	USD
CY2013	fchs	Stock Issued During Period Value Conversion Of Related Party Convertible Debt StockIssuedDuringPeriodValueConversionOfRelatedPartyConvertibleDebt	142484	USD
CY2013	us-gaap	Stock Issued During Period Value Other StockIssuedDuringPeriodValueOther	96000	USD
CY2013	fchs	Adjustments To Additional Paid In Capital Reclassification Of Derivative Liability To Equity AdjustmentsToAdditionalPaidInCapitalReclassificationOfDerivativeLiabilityToEquity	366094	USD
CY2013	us-gaap	Adjustments To Additional Paid In Capital Convertible Debt With Conversion Feature AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature	1871117	USD
CY2012	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	0	USD
CY2013	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	361284	USD
CY2012	fchs	Stock Issued For Loan Modification StockIssuedForLoanModification	0	USD
CY2013	us-gaap	Stock Issued1 StockIssued1	624000	USD
CY2012	fchs	Stock Issued For Related Party Line Of Credit StockIssuedForRelatedPartyLineOfCredit	0	USD
CY2013	fchs	Stock Issued For Related Party Line Of Credit StockIssuedForRelatedPartyLineOfCredit	142484	USD
CY2013Q4	us-gaap	Operating Loss Carryforwards OperatingLossCarryforwards	1400000	USD
CY2012Q4	us-gaap	Convertible Notes Payable ConvertibleNotesPayable	43537	USD
CY2012	us-gaap	Interest Expense Related Party InterestExpenseRelatedParty	6339	USD
CY2013	us-gaap	Interest Expense Related Party InterestExpenseRelatedParty	11153	USD
CY2013	dei	Trading Symbol TradingSymbol	FCHS
CY2014Q1	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	16793248	shares
CY2013	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2013	dei	Entity Registrant Name EntityRegistrantName	First Choice Healthcare Solutions, Inc.
CY2013	dei	Entity Central Index Key EntityCentralIndexKey	0001416876
CY2013	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2013	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2013	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2013	dei	Entity Filer Category EntityFilerCategory	Smaller Reporting Company
CY2013Q2	dei	Entity Public Float EntityPublicFloat	4844685	USD
CY2013	us-gaap	Stockholders Equity Reverse Stock Split StockholdersEquityReverseStockSplit	four-to-one (4 to 1) reverse stock split

Files In Submission

Name	View Source	Status
0001144204-14-019627-index-headers.html	Edgar Link	pending
0001144204-14-019627-index.html	Edgar Link	pending
0001144204-14-019627.txt	Edgar Link	pending
0001144204-14-019627-xbrl.zip	Edgar Link	pending
fchs-20131231.xml	Edgar Link	completed
fchs-20131231.xsd	Edgar Link	pending
fchs-20131231_cal.xml	Edgar Link	unprocessable
fchs-20131231_def.xml	Edgar Link	unprocessable
fchs-20131231_lab.xml	Edgar Link	unprocessable
fchs-20131231_pre.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xls	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
tpg12.jpg	Edgar Link	pending
tpg4.jpg	Edgar Link	pending
v371856_10k.htm	Edgar Link	pending
v371856_ex10-17.htm	Edgar Link	pending
v371856_ex10-18.htm	Edgar Link	pending
v371856_ex10-19.htm	Edgar Link	pending
v371856_ex10-20.htm	Edgar Link	pending
v371856_ex10-21.htm	Edgar Link	pending
v371856_ex10-21a.htm	Edgar Link	pending
v371856_ex10-22.htm	Edgar Link	pending
v371856_ex10-23.htm	Edgar Link	pending
v371856_ex10-24.htm	Edgar Link	pending
v371856_ex10-29.htm	Edgar Link	pending
v371856_ex10-29a.htm	Edgar Link	pending
v371856_ex10-29b.htm	Edgar Link	pending
v371856_ex10-30.htm	Edgar Link	pending
v371856_ex21.htm	Edgar Link	pending
v371856_ex31-1.htm	Edgar Link	pending
v371856_ex31-2.htm	Edgar Link	pending
v371856_ex32-1.htm	Edgar Link	pending
v371856_ex32-2.htm	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$FCHS
First Choice Healthcare Solutions Inc Stock $fchs

2013 Form 10-K Financial Statement

#000114420414019627 Filed on March 31, 2014

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$FCHS First Choice Healthcare Solutions Inc Stock $fchs

2013 Form 10-K Financial Statement

#000114420414019627 Filed on March 31, 2014

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$FCHS
First Choice Healthcare Solutions Inc Stock $fchs